CLIENT IMPACT
- Reached key decisionmakers within the Greek pharmaceutical sector
- Received clear guidance on local regulations and authority processes
- Established a presence in a previously hardtoaccess market
The challenge
For several years, AtrimusRx attempted to navigate the processes linked to the national pharmaceutical authority. Despite a scalable offering and strong customer adaptation, entering Greece proved complex and resource intensive. The company needed support to understand the market and build relevant connections.
Business Sweden's support
Business Sweden provided AtrimusRx with the local and international support needed to take the next step in its establishment. By combining market insight, networks and regulatory guidance, the team created a clear pathway into the Greek market.
- Connected AtrimusRx with Business Sweden’s office in Milan, which has deep experience of Greek business conditions
- Mapped the market and analysed regulatory requirements
- Identified and opened doors to relevant stakeholders
- Supported the company in presenting its opportunity at the correct level
Result
The collaboration gave AtrimusRX the local insight required to overcome previous barriers. With clear guidance and support from Business Sweden, the company succeeded in establishing itself in a market that had long been difficult to reach. The work has contributed to continued growth and strengthened the company’s international expansion.
About AtrimusRx
AtrimusRx is a Swedish company specialising in shortage medicines and tailored solutions that enable fast and flexible delivery to patients with specific needs.
